Cel Sci Corporation (CVM)

[Fosco1]

Interesting, not sure though what you mean by "mind blowing"

True that incidence has been growing over the years

Taïwan healthcare has always shown superior survival, so no surprise it is superior to what we have in other countries (including USA)

This being said, as compared to SEER:

I have used their definition of Oral Cavity (not exactly the same as Cel SCI) to retrieve survival from Seer

click for survival table here

Taïwan relative survival at year 5 is :

Stage III 57.1 (54.7–59.5)
Stage IV 38.9 (37.6–40.1)

Versus SEER's :

Stage III 53.6 (51.3–55.9)
Stage IVa 38.7 (37.1–40.2)

Observed survival for this Taïwan population might be 5 points below in ST III and 4 below in ST IV there fore around 52% resp 35%. So that looks about 4% above what is seen in SEER.

This is still very far away from what is observed in this trial population and in any case under my conservative assumption for SOC